Stay updated on IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a new revision entry v3.7.0 to the history, indicating a page/system update. The prior revision v3.6.6 is removed from the deletions, updating the record of changes shown on the history page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, indicating an updated version of the record, and the previous revision v3.6.5 was removed from the visible list.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page’s revision label in the footer was updated from v3.6.4 to v3.6.5, signaling a minor platform update rather than a change to the study data list. This update affects how the page presents its version, not the content of the record history.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3. This appears to be a metadata update rather than a user-facing content change.SummaryDifference0.1%

- Check80 days agoChange DetectedThe record history now shows a new revision label v3.6.3, replacing the previous v3.6.2. This indicates a backend/UI update to how the history is presented for this study page.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page’s revision label was updated to v3.6.2, replacing the previous v3.6.0, indicating a platform version update reflected in the history view rather than a modification to the study data.SummaryDifference0.1%

Stay in the know with updates to IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.